Resources to get started right

Receive guidance on copay and reimbursement matters.
Connect with experts

Questions about cutaquig?

Find helpful answers to common questions about cutaquig and PI.
Learn more
References:
  1. Cutaquig® [package insert]. Lachen, Switzerland: Octapharma AG; 2018.
  2. Kobayashi RH, Gupta S, Melamed I, et al. Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the treatment of patients with primary immunodeficiencies. Front Immunol. 2019;10(40):1-12.